상단 PC메뉴
SITEMAP · 해당 컨텐츠를 클릭하세요.
- R&D
- Business
R&D
Research & Development
본문영역
Projected Pipeline
| Items | Products | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cultured artificial RBC |
Animal RBC (dog or cat) |
Cultured RBC |
vGMP |
Animal testing |
NADA |
Sales |
||||||||||||||||||||
| Human RBC | Cultured RBC |
Pre- Clinical |
GMP |
IND |
Phase 1 |
Phase 2 |
Phase 3 |
Sales |
||||||||||||||||||
| Personalized Human RBC |
Cultured RBC |
GMP |
IND |
Clinical |
||||||||||||||||||||||
| Cell line for cultured RBC |
Cell line for animal RBC |
IP of new cell lines |
L/O |
|||||||||||||||||||||||
| Cell line for human RBC |
IP of new cell lines |
L/O |
||||||||||||||||||||||||
| Items | Products | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expansion of cultured RBC |
Culture media by-product |
Media by-product |
Animal testing |
Sales |
||||||||||||||||||||||
| DDS (RG RBC) |
DDS Platform |
RG RBC |
Pre- Clinical |
GMP |
IND |
Phase 1 |
Phase 2 |
|||||||||||||||||||
| Blood disease/ Anti-aging |
Cell Gene therapy (CGT) |
|||||||||||||||||||||||||
좌우로 움직여서 확인해주세요